In addition, a study found that PLD-specific inhibitors can reduce TAMs and TANs infiltration in tumors and decrease tumor growth in breast cancer, which may implicate PLD as a potential therapeutic target in the treatment of cancers (231). This evidence concerns the gene GPLD1 and breast cancer.